Spravato (esketamine)
Spravato and ketamine are not usually first-line treatments for depression. There are some logistical considerations for this in-office treatment but the potential benefits make it an important option.
Learn moreFDA-approved Spravato (esketamine) and ketamine can produce benefits in as few as 1–2 treatments — administered and monitored in-office by our medical team.
Spravato and ketamine are not usually first-line treatments for depression. There are some logistical considerations for this in-office treatment but the potential benefits make it an important option.
Learn moreTMS involves using non-invasive magnetic pulses to stimulate areas of your brain that depression has altered or shut down. It’s usually only used after more traditional depression treatments have failed. TMS does not require medication and patients are completely awake during the painless, outpatient treatment.
Learn moreOur medical staff will carefully identify and evaluate your symptoms to prescribe from among 5 different classes of antidepressants.
This is when a doctor prescribes additional medications to try and boost the effectiveness of your antidepressants. The most common are mood stabilizers, anti-anxiety medications, and atypicals (SGAs).
SGAs can be administered on their own or as an adjunctive antidepressant treatment. Their name is confusing as they are frequently prescribed for non-psychotic symptoms.
The first step for many people with depression is therapy. With many different types available, it can be highly customizable to suit your needs. Therapy can be separate or combined with medication.
Learn moreKetamine is in a pharmacologic class known as a “dissociative anaesthetic.” It has been FDA approved since 1970 for other uses but more recently has been shown to be effective for treating depression.
Spravato is the brand name for esketamine which is one part of the whole molecule racemic ketamine. There is good research demonstrating antidepression benefits from both compounds and we offer both options at Wave Treatment Centers. We will evaluate your symptoms to determine the best course of treatment.
Unlike traditional antidepressants which work on the monoamines (dopamine, norepinephrine and serotonin), ketamine works on the N-methyl-D-aspartate or NMDA receptor which influences the neurotransmitter glutamate. Glutamate is the predominant excitatory neurotransmitter in the brain learning, memory and neuroplasticity.
Ketamine and Spravato can produce rapid benefits, sometimes in as few as 1-2 treatments. This medication can induce a dream-like state during which patients are often able to observe their symptoms from a new perspective — which helps them to deal with them.
Spravato is not taken as a daily pill like most other antidepressant treatment methods. Instead, Spravato treatment is administered as a nasal spray. It must be prescribed and dosed at an approved treatment center such as Wave Treatment Centers under the supervision of a medical provider.
Patients give themselves the nasal spray and are monitored by a medical professional for about 2 hours after dosing. The usual dosing protocol for the first month is twice a week. For subsequent months, it is most often only dosed once every one to two weeks before moving treatments to every 3-4 weeks.
Ketamine can follow a similar regimen or may follow alternate protocols or routes of administration.
Because these medications can produce depersonalization, or the perception of being outside of yourself (dissociation), some patients describe the experience like a “waking dream.” Your vital signs will be monitored during the experience by medical staff who check your blood pressure and assess your dose response. The peak effects of the medication are generally during the first 40-60 minutes, but you will remain in the office for at least 2 hours. You may remain until you feel you are ready to leave. You cannot drive after the treatment until the next day and we will confirm that you have prearranged transportation to bring you home.
As with all medications, Spravato does carry some risk of side effects. Most of these side effects are temporary and typically go away within 24-48 hours. It is required, however, that you have someone else drive you to and from your treatments, as some of the side effects may make driving unsafe. The most common side effects experienced by Spravato users include:
For those struggling with the effects of treatment-resistant depression, the benefits often far outweigh the risks. Be sure to discuss this with your Spravato-approved physician before treatment.
When someone is experiencing symptoms of depression, they typically go through treatment options in steps until they find relief. Treatment planning may be augmented to build on initial treatments by adding medication or other modalities to further improve symptoms. See the comparison cards above for the most common options.
Every plan is different, but many PPO plans cover Spravato for treatment-resistant depression as an out-of-network benefit.
Wave is an out-of-network provider, so we don’t bill insurance directly. Our caring staff will help you understand your benefits, provide the paperwork to submit for reimbursement, and walk you through other payment options.
Our caring staff will help you understand your options for insurance and payment.
Book a consultation